MYOCURE 2nd progress meeting

Activiteit: Participation in conference


MYOCURE is a collaborative European Research and Innovation project to develop a novel, innovative and clinically-translatable one-treatment gene therapy platform for patients suffering from rare inherited muscle diseases, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II.
The MYOCURE 2nd progress meeting is to catch up on the work progress achieved in the different working groups and to discuss the upcoming timeline.
Periode19 mrt 201820 mrt 2018
LocatieParis, France
Mate van erkenningInternational